Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
Introduction and Background
Introduction
Alzheimer's disease is a progressive neurodegenerative disorder that affects memory, thinking, and behavior. It is the most common cause of dementia, accounting for up to 80% of all dementia cases (Rayathala et al., 2022). While Alzheimer's disease affects both men and women, research has shown that women are disproportionately affected by the disease (Rabipour et al., 2021). Women have a higher risk of developing Alzheimer's disease than men, and they also tend to experience more rapid cognitive decline once they develop the disease (Duarte-Guterman et al., 2021).
Background
The challenges of making an early diagnosis of Alzheimer's disease have been documented (Pais et al., 2020). However, why these challenges exist is not particularly well understood (Dubois et al., 2021). Early diagnosis is crucial because it allows for early intervention and treatment, which can slow the progression of the disease and improve quality of life for patients and their families (Rasmussen & Langerman, 2019). However, making an early diagnosis of Alzheimer's disease can be particularly challenging for women (Ferretti et al., 2020).
It is unclear why early diagnosis of Alzheimers for women is challenging for physicians, but a challenge it certainly is (Dubois et al., 2021). Researchers have, however, presented different theories as to why this challenge exists, including atypical presentation, delayed presentation, bias in research, and differences in brain structure and function (Duara & Barker, 2022; Lopez et al., 2020).
Duara and Barker (2022) argue that women may present with atypical symptoms that are not always recognized as being related to Alzheimer's disease. For example, women may be more likely to experience mood changes, anxiety, and sleep disturbances than men, which could be mistaken for other conditions. Or, women may be more likely to delay seeking medical attention for cognitive symptoms or may not report them at all due to social stigma or shame. This can delay the diagnosis and treatment of Alzheimer's disease (Lopez et al., 2020). Also, historically, Alzheimer's disease research has been biased towards studying men, leading to a lack of understanding of how the disease manifests in women (Ferretti et al., 2020). This can result in misdiagnosis or delayed diagnosis of Alzheimer's in women. Finally, studies have shown that women's brains may be more resilient to the effects of Alzheimer's disease, making it harder to detect the disease in its early stages (Veitch et al., 2022). Plus, women may have a higher burden of certain types of Alzheimer's-related brain changes, such as tau tangles, which can be harder to detect with current diagnostic tools (Veitch et al., 2022).
Relevance and Importance
The...…sheds light on broader issues related to health disparities and gender bias in medicine (Lopez et al., 2020). It highlights the need for more research and attention to be paid to how diseases present differently in different populations, and the need for more inclusive research practices that account for diversity and inclusivity in medical research.
Prior Research
Prior research has shown that women are more likely than men to develop Alzheimer's disease, and that they experience more rapid cognitive decline once they develop the disease (Duarte-Guterman et al., 2021). Some studies have also suggested that women may be more sensitive to the effects of Alzheimer's disease pathology in the brain (Duara & Barker, 2022; Lopez et al., 2020). However, research on the challenges of making an early diagnosis of Alzheimer's disease in women is limited (Dubois et al., 2021).
The challenges of making an early diagnosis of Alzheimer's disease in women are significant and multifaceted. There is a need for more research to understand the specific challenges that women face in receiving an early diagnosis of Alzheimer's disease, and to develop effective strategies for addressing these challenges. This study seeks to address this need by exploring the challenges of making an early diagnosis of Alzheimer's disease in women, and through that exploration making inroads into…
References
Duara, R., & Barker, W. (2022). Heterogeneity in Alzheimer’s disease diagnosis and progressionrates: Implications for therapeutic trials. Neurotherapeutics, 19(1), 8-25.
Duarte-Guterman, P., Albert, A. Y., Barha, C. K., Galea, L. A., & Alzheimer’s DiseaseNeuroimaging Initiative. (2021). Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memory. Psychoneuroendocrinology, 129, 105248.
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., ... & Feldman,H. H. (2021). Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet Neurology, 20(6), 484-496.
Ferretti, M. T., Martinkova, J., Biskup, E., Benke, T., Gialdini, G., Nedelska, Z., ... & Schmidt,R. (2020). Sex and gender differences in Alzheimer’s disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology. European journal of neurology, 27(6), 928-943.
Lopez, R. P., Rose, K. M., Kenney, L., Sanborn, V., & Davis, J. D. (2020). Managing shame: Agrounded theory of how stigma manifests in families living with dementia. Journal of the American Psychiatric Nurses Association, 26(2), 181-188.
Pais, M., Martinez, L., Ribeiro, O., Loureiro, J., Fernandez, R., Valiengo, L., ... & Forlenza, O.
V. (2020). Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges. Brazilian Journal of Psychiatry, 42, 431-441.
Rabipour, S., Rajagopal, S., Pasvanis, S., Rajah, M. N., & PREVENT-AD Research Group.
(2021). Generalization of memory-related brain function in asymptomatic older women with a family history of late onset Alzheimer's Disease: Results from the PREVENT-AD Cohort. Neurobiology of Aging, 104, 42-56.
Rasmussen, J., & Langerman, H. (2019). Alzheimer’s disease–why we need earlydiagnosis. Degenerative neurological and neuromuscular disease, 123-130.
Rayathala, J., Kumar, K., & Venkatesh, P. (2022). Review on Alzheimer’s disease: Past, presentand future. Journal of Innovations in Applied Pharmaceutical Science (JIAPS), 28-31.
Veitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., DeCarli, C., Green, R. C., ... &Alzheimer's Disease Neuroimaging Initiative. (2022). Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease. Alzheimer's & Dementia, 18(4), 824-857.
ALZHEIMER'S DISEASE Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Efforts to develop a drug for Alzheimer's disease, which mostly affect people in older age, have not been successful. Instead, most of the treatments offered often target the behavioral symptoms of the affected individual, but not the cause of the disease. The occurrence
Alzheimer Healthy Community PLANNED, PERSONALIZED CARE Alzheimer's Healthy Community Dog-Assisted Therapy for Older People with Dementia A review of nine studies on the subject produced loose conclusions on the value of this type of therapy (Perkins et al., 2008). They, however, established a trend, indicating increased social behavior and decreased agitation when dogs were in the company of the respondents. This improvement in social behavior was unrelated with the severity of the respondents' dementia.
What is worth noting here is the fact that behavior disturbances, ranging in severity from repeated questioning to physical violence, are common (National Institute of Mental Health, 1989). It is unclear whether Alzheimer's disease represents a single entity or several variants. Some experts believe that there are distinct subtypes of Alzheimer's disease, such as Lewy body disease (in which the signs of Parkinson's disease, visual hallucinations or alterations in alertness
Some treatments may actually help with the disease. Diets and dietary supplements Eating vegetables like broccoli and spinach may help older women [and probably men] retain some memory abilities later on, while avoiding obesity in middle age lowers the risk of later Alzheimer's disease in both sexes, new studies suggest." The effect of the vegetables probably comes from the antioxidants and B. vitamins they contain (Ritter, 2004). Herbal remedies and other dietary
Alzheimer's Disease currently affects more than four million Americans. Alzheimer's is a disease characterized by the progressive degeneration of areas within the brain, resulting in cognitive and physical decline that will eventually lead to death. It is important to emphasize that Alzheimer's disease (AD) is not a normal part of aging. Although AD typically appears in those over sixty-five, it is a neurodegenerative disease, quite distinct from any aging-related cognitive
Scientists are racing to find a cure as millions of people reach the age when Alzheimer's is most commonly manifested (Plontz). Experts are still trying to fully understand the cause or causes of Alzheimer's disease. In the meantime, it's helpful to understand the hallmarks of Alzheimer's -- plaques and tangles -- and the risk factors that affect a person's likelihood of developing the disease (Hill). Alzheimer's disease is characterized by a